Stocktoria
Lexeo Therapeutics, Inc. LXEO
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-11-03
Lexeo Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 3,898,570 | $18.1M | 5.34% |
| MILLENNIUM MANAGEMENT LLC | 2,833,622 | $13.2M | 3.88% |
| BlackRock Finance, Inc. | 791,584 | $12.7M | 1.08% |
| AQR CAPITAL MANAGEMENT LLC | 256,661 | $1.2M | 0.35% |
| RENAISSANCE TECHNOLOGIES LLC | 250,365 | $1.2M | 0.34% |
| D. E. Shaw & Co., Inc. | 19,866 | $92,476 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.